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Foreword
For nearly 90 years, the Veterans Affairs
Research and Development program has
been improving Veterans’ lives.
VA Research is unique in that it is the only program in the United States focused 
entirely on conducting research to address the full spectrum of Veterans’ health
needs. The program beneﬁts from being part of a comprehensive health care 
system with state-of-the art electronic medical records. Plus, most VA researchers are
also clinicians who are directly involved in providing care to Veterans. Through this 
dynamic combination of factors, VA has become a model for conducting scientiﬁcally
rigorous research—in the lab, the clinic, and the community—that is highly relevant
to patients’ needs.  Through a variety of initiatives, VA is now working more eﬀectively
than ever to translate the results of its research into everyday care to beneﬁt Veterans
and their families—and in many cases, all Americans and people around the world. 
We invite you to read through this publication and to visit our website 
(www.research.va.gov) to view the Web version, which contains links to all the 
references cited. 
2013 Highlights
• Announced the formation of new research consortia, funded jointly by VA
and the Department of Defense, to study PTSD and traumatic brain injury.
• Published results from a major study of abdominal aortic aneurysms that
provided valuable guidance on surgical treatment options.
• Funded new types of centers of excellence—Collaborative Research to 
Enhance Transformation and Excellence (CREATE) and Centers of Innovation
(COINs)—that promise to speed the translation of research results into 
clinical practice in VA.
• Reported results from a large prostate cancer trial that shed important light
on the relative beneﬁts and risks of surgery and radiation.
• Played a key role in University of Pittsburgh-led research on a 
brain-computer system that enabled a woman with total paralysis to 
control a robotic arm using only her thoughts.
• Published ﬁndings from the ﬁrst rigorous, large-scale comparison of diﬀerent
methods to wean patients with breathing diﬃculties from ventilators.
• Reported that infections acquired in the hospital are less likely to occur
when acute-care patients are bathed daily with a simple, inexpensive antiseptic.
• Began collaboration with the Department of Defense on a $6.5 million study
to learn whether Vietnam Veterans with traumatic brain injury or PTSD 
are at higher risk for Alzheimer's disease as they age.
• Reported positive results from one of the largest studies to date on the use
of videoconferencing to deliver evidence-based psychotherapy for Veterans
with PTSD.
• Found that many Veterans suﬀering from blast concussions may have 
hormone deﬁciencies that mimic some of the symptoms of PTSD and 
depression, underscoring the value of hormone-based treatments for 
traumatic brain injury.
• Published new data indicating that Veterans exposed to Agent Orange are
not only at higher risk for prostate cancer, but also more likely to have 
aggressive forms of the disease—information that could help guide 
screening and treatment.
• Disseminated information to gastroenterologists on innovative research-
based methods to improve the cancer-detection rate of colonoscopy.
• Contributed to new clinical guidelines for cholesterol management.
• Collaborated with researchers in Europe and Israel to develop and test a new
type of “artiﬁcial pancreas” that could lead to major improvements in care 
for diabetes, and that promises to impact cell therapy for a variety of other
chronic health conditions.
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VA has a comprehensive 
research agenda to help the
newest generation of 
Veterans—those returning
from operations Enduring
Freedom, Iraqi Freedom, and
New Dawn. In addition to 
exploring new treatments for
traumatic brain injury and
other complex blast-related 
injuries, VA researchers are 
examining ways to improve the
delivery of health care services
for these Veterans and promote
their reintegration back into
their families, communities,
and workplaces.
Afghanistan/Iraq
Recent Advances 
Using the Internet to help smokers quit — A four-year study at the Durham VA
aims to learn whether OEF/OIF Veterans who smoke will be more successful at
quitting with the help of the website QuitNet. More than 400 Veterans are taking
part in the research, due to end in early 2014. Based on U.S. Public Health Service
guidelines, QuitNet features chat rooms, advice from experts, medication tips,
buddy match-ups, social media space, and other tools to support smokers in
their quest to stop smoking.  Half of the Veterans in the study have received pre-
mium membership to QuitNet. They have also been oﬀered nicotine replacement
therapy from VA. The other study participants are getting standard care. This
means referral to a clinic geared to help returning Veterans quit smoking.
(www.clinicaltrials.gov, NCT01001546)
Study to examine lung function — VA has begun a study of health eﬀects 
related to burn-pit exposure during deployment to Iraq or Afghanistan. An October
2011 report by the Institute of Medicine suggested a link between burn pits and
compromised lung function. Burn pits are open pits where trash and other waste
is burned. Completed studies on environmental exposures in Afghanistan/Iraq
and lung health have shown mixed results.  (Federal Register announcement of 
VA study, February 2013)
Similar deployment stressors among male, female Veterans — A survey of
more than 3,300 OEF/OIF Veterans found that although male and female Veterans
experienced diﬀerent stressors during deployment, their readjustment to civilian
life was similar. However, women were nearly nine times as likely to report sexual
harassment as a source of stress. Men were more likely to report combat as a
source of stress, although 73 percent of women were exposed to some combat
or to combat aftermath. As for eﬀects of stress, men and women were equally
likely to report PTSD. Men were more likely to report problematic alcohol use,
and women were slightly more likely to report anxiety and depression. The study,
from the Boston VA, is one of the ﬁrst and largest to compare male and female
experiences of OEF/OIF Veterans. (Journal of General Internal Medicine, July 2013)
Afghanistan/Iraq
Facts about 
OEF/OIF Veterans
• Due to improved body armor and
battleﬁeld medicine, the patterns
of injury in OEF/OIF Veterans diﬀer
from those in previous wars. For
example, OEF/OIF soldiers have
lower numbers of chest injuries,
but higher numbers of head and
neck injuries, compared with soldiers
in Vietnam and World War II. They
also have fewer gunshot injuries
but more blast-related injuries. 
• Many OEF/OIF soldiers have 
returned home with complex, 
multiple injuries. These can include
brain and spinal cord injuries, 
vision and hearing loss, nerve 
damage, burns, amputations, 
musculoskeletal injuries, infections,
posttraumatic stress disorder,
chronic pain, and problems 
readjusting to civilian life. 
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Areas of focus for VA research
on Alzheimer’s disease include
finding potential drug therapies
for prevention and treatment,
exploring the genetic and 
environmental causes of the
disease, studying the best ways
to provide long-term care, and
evaluating new programs to
support caregivers.
Additionally,VA researchers are
working to better understand
the connection between
Alzheimer’s and other chronic
diseases, such as diabetes. 
Alzheimer’s Disease
Recent Advances 
Beta-blockers reduce Alzheimer’s risk — Men who take beta-blockers for high
blood pressure appear to be at lower risk for Alzheimer’s, and for dementia in
general. Two studies from the Hawaii VA focused on men who were part of the
Honolulu-Asia Aging Study. One study followed 2,197 men with high blood 
pressure for up to 18 years. About 39 percent developed problems with thinking
and memory. Men taking only beta-blockers for their high blood pressure had a
31 percent lower risk of developing these problems, compared with men who
took other drugs. A second study examined the brain tissue of a group of de-
ceased men who had been part of the study. Their brains were analyzed for le-
sions characteristic of Alzheimer’s disease and dementia. Men without high
blood pressure had the lowest numbers of lesions. Among men with high blood
pressure, those taking only beta-blockers had fewer lesions than men taking
other drugs.  (Neurology, September 2013)
Nursing home intervention — A program called STAR-VA helps to lessen 
challenging dementia-related behaviors, such as aggression, wandering and 
resistance to care. The program was tested in 17 VA nursing homes. A psychologist
or similar care provider led a team to establish a personalized plan for each patient.
The program identiﬁed triggers to challenging behaviors, as well as consequences.
Nurses and other personnel worked to improve communication with patients
and scheduled personalized, pleasant experiences (such as taking a walk outside
or listening to an audio book). In addition to reducing challenging behaviors, the
program reduced depression and anxiety.  (Psychological Services, online Aug. 12,
2013)
Exercise may prevent dementia, even in oldest old — A VA study conﬁrms
that physical activity reduces the risk of dementia in very elderly women. Re-
searchers from the San Francisco VA followed 1,249 women for ﬁve years. The av-
erage age of the women at the beginning of the study was 83. After ﬁve years,
women 85 and older were tested. Those who had spent the most time walking
were about half as likely to show symptoms of dementia, compared with those
who did the least amount of exercise. Other studies have shown a beneﬁt of exer-
cise in younger people; this was the ﬁrst study to focus on people 85 and older.
(American Journal of Geriatric Psychiatry, online July 3, 2013)
Alzheimer’s Disease
Facts about Alzheimer’s
Disease
• Alzheimer’s disease is the sixth
leading cause of death in the
United States. 
• In Alzheimer’s disease, nerve cells
in the brain become damaged or
die. This aﬀects thoughts, memory,
and language.  
• Symptoms range from mild 
forgetfulness to the inability to
perform everyday tasks.  
• People with Alzheimer’s have
high levels of beta-amyloid plaque
in their brains. They also have 
tangled ribbons of a protein 
called tau. 
• Alzheimer’s is estimated to aﬀect
some 5.2 million Americans. By
2050, it could aﬀect as many as
13.8 million.   
• The annual indirect and direct
costs of care for Alzheimer’s dis-
ease in the U.S. are estimated at
$203 billion.
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Arthritis describes a complex
family of diseases that affect
people of all ages. 
VA researchers are working to
understand the biological causes
of arthritis, with a focus on 
osteoarthritis and rheumatoid
arthritis. VA research includes
understanding the risks for the
diseases, how other conditions
(such as PTSD or alcohol 
dependence) may affect arthritis
severity, the most effective
medical and intervention 
strategies, and the risks and
outcomes of joint replacement
surgery. 
Arthritis
Recent Advances 
Nanomedicine may halt arthritis progression — A protein called vasoactive 
intestinal peptide, or VIP, has anti-inﬂammatory eﬀects. VIP has shown promise in
treating arthritis, but the protein breaks down quickly. When VIP is combined
with a group of molecules called sterically stable micelles (SSM), it is stabilized for
longer time periods. Researchers from Jesse Brown VA Medical Center in Chicago
tested the eﬀects of VIP-SSM on arthritis in mice. The protein reduced joint
swelling and stopped the destruction of bone and cartilage. It also reduced levels
of inﬂammatory and autoimmune blood markers that are used to test for
rheumatoid arthritis. There were no side eﬀects. (Molecular Pharmaceutics, Feb. 4,
2013)
Program increases knee replacement in African Americans — African Ameri-
cans are less likely than whites to undergo knee replacement surgery. An educa-
tional video or brief counseling session may help. Philadelphia VA researchers
enrolled 639 African-American patients from three VA clinics. All had moderate to
severe osteoarthritis of the knee. They were randomized to receive brief counsel-
ing, the viewing of an arthritis decision-aid video, both interventions, or neither.
Before the intervention, 67 percent of the patients were willing to consider knee
replacement surgery. This rose to 75 percent after the interventions. Twelve
months later, patients who had any type of intervention were more likely to dis-
cuss their knee pain with their doctor and to receive a referral to an orthopedic
surgeon. (Arthritis and Rheumatism, May 2013)
Extra drug gives no added relief to people with gout — The drug rilonacept
provides no extra beneﬁt to people with acute gouty arthritis, according to a clin-
ical trial at the San Diego VA that included 225 adults. One-third of the patients
received injections of rilonacept, which blocks a protein that causes inﬂamma-
tion. One-third received pills containing indomethacin, the standard drug given
for gout ﬂare-ups. The ﬁnal one-third received both drugs. All groups reported
pain relief, but rilonacept did not treat pain better than indomethacin. And peo-
ple who took both drugs did not feel greater pain relief than people in the other
groups. (Arthritis Research and Therapy, online Feb. 1, 2013)
Arthritis
Facts about 
Osteoarthritis and 
Rheumatoid Arthritis
• Arthritis is an umbrella term for
more than 100 conditions that 
aﬀect the joints, muscles, cartilage,
and bone. 
• Osteoarthritis, or degenerative
joint disease, is one of the most
common forms. According to the
Arthritis Foundation, it aﬀects up
to 27 million Americans, most of
them elderly. 
• Rheumatoid arthritis is the
second most common type of
arthritis, aﬀecting about 1.3 million 
Americans. About 70 percent are
women. In people with rheumatoid
arthritis, the body’s immune system
attacks its own joint tissue, causing
inﬂammation. Researchers have
identiﬁed genes that confer an 
increased risk for rheumatoid
arthritis. 
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Many forms of complementary 
and alternative medicine, 
commonly referred to as CAM,
are popular among Veterans.
VA researchers are conducting
rigorous scientific evaluations
of CAM treatments that have
shown promise in pilot studies
or small clinical trials. In some
cases they are conducting lab
studies to explore the 
physiological and biological
basis of these treatments.
Among the therapies under 
investigation are meditation,
acupuncture, massage, yoga,
and nutritional or herbal 
supplementation. 
Complementary & 
Alternative Medicine
Recent Advances 
Johrei therapy shows promise for sleep diﬃculty — More than 3 million
Japanese families practice Johrei, which means “puriﬁcation of the spirit.”  The
idea behind Johrei, a non-touch healing therapy, is that the body can purify itself.
Southern Arizona VA researchers tested the eﬀects of Johrei on sleep disruptions
in mice. They purposely used animals rather than people to isolate the physiolog-
ical eﬀects of the therapy and rule out any placebo eﬀect. Some mice were dis-
rupted during sleep. Others were disrupted and given Johrei therapy. The
researchers monitored sleep using certain brain tissue markers. They found that
sleep quality was substantially better among the mice receiving the therapy.
Johrei therapy is under study in the U.K. for breast cancer and eczema.  (Explore,
March–April 2013)
Meditation and mindfulness for PTSD — Puget Sound VA researchers found
that both meditation and mindfulness improve PTSD symptoms. In the medita-
tion study, Veterans received weekly training in loving-kindness meditation for 12
weeks. After three months, they showed reduced PTSD symptoms, as well as 
reduced depression. A separate study analyzed the eﬀects of mindfulness-based
stress reduction on PTSD. After four months, those in the stress reduction program
had better mental-health-related quality of life, fewer PTSD symptoms, and less
depression. (Journal of  Traumatic Stress, August  2013; Journal of Clinical Psychology,
January 2013)
Acupuncture to ease insomnia in OIF/OEF Veterans — A VA study is underway
to explore how group ear acupuncture may help OIF and OEF Veterans with
PTSD-related insomnia. A 2009 review of 46 published studies showed that
acupuncture was at least as eﬀective as sleep-inducing medications. The War-
Related Illness and Injury Study Center at the VA Medical Center in Washington,
DC, provides individual acupuncture treatments and group ear acupuncture
treatments. Ear acupuncture focuses on speciﬁc spots on the ear that are thought
to promote health and well-being. (www.warrelatedillness.va.gov)
Complementary & 
Alternative Medicine
Facts about 
Complementary and 
Alternative Medicine
• According to a 2011 survey by
VA's Health Care Analysis and Infor-
mation Group, the use of comple-
mentary and alternative medicine
has grown substantially in VA over
the past decade.  About 9 in 10 VA
facilities now directly provide CAM
therapies or refer patients to out-
side licensed practitioners. 
• In a survey of 125 VA facilities:
– 101 said they provide meditation
– 93 provide stress management/
relaxation therapy
– 82 provide guided imagery
– 62 provide animal-assisted therapy
– 58 provide acupuncture
– 44 provide yoga
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VA conducts a broad array of 
research on cancers common
among Veterans. These include
diseases such as prostate, lung,
colorectal, bladder, kidney,
pancreatic, esophageal and
breast cancer, as well as 
lymphomas and melanomas.
VA researchers carry out 
lab experiments aimed at 
discovering the molecular and
genetic mechanisms involved in
cancer; epidemiologic studies
looking at the causes of disease;
clinical trials to evaluate new
or existing treatments; and
studies focused on improving 
end-of-life care. 
Cancer
Recent Advances 
Diagnosing pancreatic cancer earlier — A type of lab-engineered molecule
called a monoclonal antibody may allow for diagnosing pancreatic cancer more
than two years before symptoms appear. Researchers at the Philadelphia VAMC
tested whether the monoclonal antibody Adnab-9 attached to stool samples
from people with or without pancreatic cancer. They found that it could diﬀerentiate
cancer patients from healthy controls. More than 90 percent of pancreatic cancer
cases are diagnosed at later, less curable stages, making the chances of survival
quite low. Currently, only two percent of people diagnosed with metastatic 
pancreatic cancer will survive past ﬁve years.  (Digestive Diseases and Sciences,
March 2013)
Curcumin active against drug-resistant cancer cells — A compound found 
in the spice turmeric may make drug-resistant cancer cells vulnerable to
chemotherapy. Researchers from the John D. Dingell VAMC in Detroit tested 
diﬂuorinated curcumin on drug-resistant colon cancer cell lines in a mouse
model. Curcumin blocked the activity of a microRNA, miR21, which is found at
high levels in drug-resistant colon cancer cells. As a result, miR21 could no longer
block the expression of a gene called PTEN, a common tumor suppressor gene.
Reactivating PTEN makes the drug-resistant cancer cells less “cancer-like” and
could make them susceptible to chemotherapy.  (PLoS One, July 24, 2013)
Financially burdened patients skip medicine — Nearly half of cancer patients
in a Durham VAMC study did not take medicine as directed because they 
were trying to save money. The study included 164 patients who were part of a 
national copay assistance program. Due to cost, 27 percent said they did not ﬁll a 
prescription. Twenty-ﬁve percent ﬁlled a partial prescription, and 22 percent took
less medication than prescribed. Four percent took medicine that was prescribed
for someone else. Those with a prescription drug plan were 73 percent less likely
to try one of these money-saving strategies. The unemployed were more than six
times as likely to try at least one. (Journal of Oncology Practice,  November 2013)
Cancer
Facts about Cancer
• More than 1 million Americans
are diagnosed with cancer each
year. Half of men and one-third 
of women will get cancer in their
lifetime.
• Cancer is a general term for more
than 100 diseases. In all forms of
cancer, cells in the body begin to
grow and multiply abnormally.
They can spread, invading and 
destroying normal tissue. 
• Many factors can combine to 
increase the risk of cancer. They 
include genetic makeup and 
exposures to radiation, air pollution
or other toxins, as well as more
modiﬁable, behavioral factors such
as lack of exercise, smoking, and
poor eating habits. 
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Areas of focus for VA research
on cardiovascular disease 
include evaluating and 
developing new treatments,
probing the genetic and lifestyle
causes of cardiovascular
disease, and developing new 
rehabilitation methods, 
especially for stroke. Studies
range from biomedical lab 
experiments on animal models
of heart disease to large, 
multisite drug studies and
other clinical trials involving 
thousands of patients.
Cardiovascular Disease
Recent Advances 
Drug reduces mortality in heart-failure patients — The drug serelaxin im-
proves breathing problems and reduces the risk of mortality in people with heart
failure. San Francisco VAMC researchers enrolled 1,161 patients and randomized
them to receive an intravenous infusion of either serelaxin or placebo. All patients
had been admitted to the hospital with symptoms of heart failure. The primary
endpoint was relief of dyspnea, or shortness of breath. Patients receiving serelaxin
did have fewer episodes of shortness of breath. They also had a 37 percent lower
risk of mortality during the ﬁrst 180 days: In the serelaxin group, 42 patients died,
compared with 65 in the placebo group. Serelaxin is a manufactured form of
human relaxin-2, a protein that, among other functions, helps to control blood
ﬂow to the heart and kidneys.  (Lancet, Jan. 5, 2013)
AnkleBot helps stroke survivors walk again — A two-year VA study is focused
on a rehabilitative robot that may help stroke survivors improve their gait even
years after a disabling attack. Researchers from the Baltimore VAMC are testing
the device, which is used on a treadmill. Electronic plates monitor pressure in
each foot and feed the data to a computer. The computer drives pistons on either
side of the ankles, which help with balance. As a person’s gait improves, the 
computer does less work. After two months, one participant could walk 25 feet
without assistance and climb stairs two at a time.  (Journal of Rehabilitation 
Research and Development, Vol. 50, No. 14, 2013; NeuroRehabilitation, 2013) 
New anti-inﬂammatory drug shows promise — High blood levels of C-reactive
protein (CRP) indicate inﬂammation in the body. Increased CRP puts people at
risk for diabetes, high blood pressure and cardiovascular disease. Researchers at
the Mather (Calif.) VAMC have identiﬁed a molecule that blocks the activity of
CRP in lab tests. It showed the same activity in a rodent model. Blocking CRP 
activity resulted in lower blood levels of other inﬂammatory molecules. 
(Metabolic Syndrome and Related Disorders, June 2013; International Journal of 
Cardiology, Oct. 9, 2013)
Cardiovascular Disease
Facts about 
Cardiovascular Disease
• Cardiovascular disease is an 
umbrella term for diseases and
conditions that aﬀect the heart
and blood vessels. These include
stroke, heart attack, congestive
heart failure, coronary artery disease,
and congenital heart defects. 
• Cardiovascular disease is 
America’s number-one killer, 
causing about 1 of every 4 deaths
in the United States. And 1 in 3
Americans has some form of CVD.
• CVD is the leading cause of 
hospitalization in the VA health
care system. 
• The strongest risk factors are
high blood pressure, high LDL
(“bad”) cholesterol, and smoking.
• Heart disease and stroke cost
more than $312 billion a year.
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Caring for an injured, disabled
or ill family member can entail
emotional, physical and 
financial strain. Several VA
studies are looking at the 
impact of caregiver education
and stress-reduction programs
on caregiver and Veteran
health and wellness. Studies
focus both on the short- and
long-term needs of caregivers,
as many of these individuals will
provide care for years or even
decades. VA investigators are
also developing and refining
questionnaires to help better
understand and address 
caregiver needs. 
Caregiving
Recent Advances 
Caregivers boost self-care programs for diabetes, depression — People with
diabetes or depression are more likely to participate in a self-care program if an
informal caregiver, such as a family member, is also involved. Researchers from
the Ann Arbor VA studied 727 people invited to participate in a yearlong 
Interactive Voice Response (IVR) program. Of these, 65 percent chose to have
feedback on their progress shared with a caregiver. Patients whose caregivers
also were involved were 36 percent more likely to fully participate. IVR enables
patients to communicate with health care providers via a mobile or landline
phone. Patients listen to recorded messages and respond to questions using the
keypad. They then receive tailored information based on their responses.  
(Medical Care, March 2013)
Study predicts increased need for caregivers — People may live to older ages
in the future, but more than half will need someone to help them with daily 
activities, says a study from the San Francisco VAMC. Researchers interviewed
more than 8,000 people who were part of the National Health and Retirement
Study. All were at least 50 when they enrolled in the study, and all died between
1995 and 2010. Among those who lived into their 90s, half needed a caregiver
during their ﬁnal years. And 70 percent had trouble walking during the last two
years of their life, regardless of how old they were when they died. Women were
more likely than men to be disabled near the end of life.  (JAMA Internal Medicine,
Sept. 9, 2013)
Caregiver support and chemotherapy — Ann Arbor researchers are completing
a ﬁve-year study to see if Web-based support for caregivers can help Veterans 
undergoing chemotherapy. The study is enrolling 308 patient-caregiver teams.
All will receive 10 weeks of automatic symptom assessment via phone. Half also
will receive personalized feedback on symptom management and problem-solving
advice, both to the patient and the caregiver. So far, preliminary results show that
those enrolled with caregivers can tolerate more chemotherapy and are 60 percent
less likely to discontinue it. ("Web-based support for caregivers of Veterans under-
going chemotherapy," www.hsrd.research.va.gov)
Caregiving
Facts about Caregiving
• Estimates vary widely on how
many Americans are now care-
givers for loved ones, but the
Department of Health and Human
Services estimates that up to 
37 million U.S. adults will be 
caregivers by 2050, an 85 percent
increase from 2000. 
• The burden of caregiving tends
to fall disproportionately on
women. Nationwide, about 
65 percent of caregivers are 
female. Among caregivers of 
Veterans, 96 percent are female. 
• Because of the younger ages at
which Veterans become disabled,
caregivers of Veterans are more
likely to have the caregiving role
for more than 10 years. 
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As part of a comprehensive 
research agenda to help 
advance depression care, 
VA researchers are developing,
testing, and implementing new 
models of primary care that do
a better job of screening for and
treating the disease. They are
also studying ways to improve
outcomes for Veterans affected
by depression along with other
conditions, such as heart disease
or diabetes, and exploring the
genetic and molecular roots of
the condition, with the goal of
developing more effective drugs.
Depression
Recent Advances 
ACT training improves outcomes — Acceptance and commitment therapy
(ACT) is eﬀective for depression, says a study based at the Palo Alto VA. Nearly
400 VA therapists nationwide treated 745 patients. The patients’ average depression
survey scores dropped from 30 (“severe depression”) to 19 (“mild depression”).
ACT helps patients stay in the present moment and allow their thoughts and 
feelings to come and go without struggling with them.  (Behaviour Research and
Therapy, September 2013)
Brain diﬀerences in older people with depression — A study at the 
San Francisco VA tracked brain changes in people with late-life depression.  
Researchers conducted functional magnetic resonance imaging (f-MRI) on 22
people with and 12 people without the condition. Those with late-life depression
had a thinner cortex in the right frontal, parietal, and temporal regions of the
brain. These patients then underwent 12 weeks of psychotherapy. Half did not 
respond. Compared with those who did respond, non-responders had a thinner
cortex in several areas of the brain. The cortex is the outermost layer of brain 
tissue; it is also referred to as “gray matter.” Further research could lead to 
customized treatment based on brain morphology.  (American Journal of Geriatric
Psychiatry, August 2013)
Low blood pressure linked with depression, anxiety — People 50 and older
with low blood pressure are more likely to have symptoms of depression or anxiety,
says a study from the Palo Alto VA. The study involved 4,179 people ages 50 to 104.
Besides taking blood-pressure measurements, researchers had people complete
two common questionnaires to assess depression and anxiety. Anxiety was
linked with low systolic blood pressure (the ﬁrst, higher number), and depression
with low diastolic blood pressure (the second, lower number). Other studies have
suggested a relationship between extremes in blood pressure and mental health
conditions, but past evidence has been conﬂicting.  The research may help to
better identify older people at risk for depression and anxiety.  (International 
Journal of Geriatric Psychiatry, October 2013)
Depression
Facts about Depression
• In any given year, nearly 
1 in 10 U.S. adults will experience
depression.
• An untreated episode of 
depression may last several
months, and most people with 
depression experience repeated
episodes over a lifetime.
• About 14 percent of Veterans
have been diagnosed with 
depression, but due to under-
diagnosis, the actual percentage 
is likely higher. Even among those
diagnosed, as many as two-thirds
receive little or no treatment 
during the ﬁrst year after diagnosis.
• Depressed male Veterans are
three times as likely as depressed
female Veterans to commit suicide.
The risk for suicide also is higher in
Caucasian Veterans, compared
with African Americans.
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VA researchers are studying 
innovative strategies and 
technologies—including group
visits, telemedicine, peer 
counseling, and Internet-based
education and case manage-
ment—to enhance access to 
diabetes care and to improve
outcomes for patients. In 
addition, VA researchers are
working to develop better ways
to prevent or treat diabetes,
particularly in special 
populations such as the elderly, 
amputees, minorities, spinal
cord injured patients, and those
with kidney or heart disease.
Diabetes
Recent Advances 
Study to ﬁnd best diabetes drug combination — The Atlanta VA is participating
in a new National of Institutes of Health study to compare the long-term beneﬁts
and risks of four diabetes drugs in combination with metformin. Metformin is the
ﬁrst medication typically used when treating type 2 diabetes. If it does not control
the disease, doctors may add one of several other drugs, all of which have low-
ered blood-sugar levels in short-term studies. However, no long-term study has
focused on which drug combination works best and has the least side eﬀects.
The four drugs being studied are sulfonylurea, dipeptidyl peptase-4 (DPP-4) 
inhibitor, glucagon-like peptide (GLP)-1 agonist, and long-acting insulin. The 
NIH-funded project will compare eﬀects on blood glucose levels, diabetes 
complications, and quality of life. The study is slated to last ﬁve years.  
("NIH begins recruitment for long-term study of diabetes drug eﬃcacy," June 3, 2013,
www.nih.gov)
Low blood sugar, dementia linked — Diabetics with an episode of low blood
sugar may be more likely to develop dementia, according to a study from the 
San Francisco VAMC. The study included 783 older adults (average age 74) with
diabetes. Over 12 years, those who experienced low blood sugar (hypoglycemia)
were twice as likely to later be diagnosed with dementia. Adults who developed
dementia were three times as likely to later experience low blood sugar. Stroke,
heart attack and high blood pressure did not factor into the relationship.  
(JAMA Internal Medicine, July 22, 2013)
Poor sleep predicts diabetes — In a VA study that was part of the larger 
Millennium Cohort Study, sleep apnea and poor sleep quality predicted diabetes,
independent of other diabetes risk factors or mental health. Sleep apnea increased
risk 78 percent. Trouble sleeping increased risk 21 percent. The study, by researchers
at the Puget Sound VA, included 47,093 military members and Veterans with an
average age of about 49. There were six years of follow-up. Over that time, 871
people were diagnosed with diabetes. The researchers took other factors into 
account, such as depression, PTSD, anxiety, older age, and obesity. 
(Diabetes Care, October 2013) 
Diabetes
Facts about Diabetes
• Diabetes is a chronic disease in
which the body cannot produce 
or properly use insulin. Normally, 
insulin brings sugar out of the
bloodstream and into cells. If the
body cannot make insulin or does
not respond to it, the sugar stays 
in the blood, where it damages
blood vessels and organs.
• More than 90 percent of adults
with diabetes have type 2 diabetes,
in which the body produces insulin
but does not respond to it properly.
• About a quarter of the Veterans
receiving care from VA have 
diabetes, and more are at risk 
due to overweight or obesity. 
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Areas of focus for VA research
on gastrointestinal health 
include stomach ulcers, 
irritable bowel syndrome,
inflammatory bowel disease,
gastroesophageal reflux 
disease, and gastrointestinal
cancers. VA researchers are
looking for potential drug 
therapies, exploring less 
invasive treatments, and 
seeking supportive strategies
for Veterans during and after
treatment.
Gastrointestinal Health
Recent Advances 
Steroids up risk of low bone density in men — A study of 34,665 Veterans
found that men taking steroids for ulcerative colitis were nearly nine times as
likely to develop low bone-mineral density, compared with non-steroid users.
Southeastern Louisiana VA researchers led the analysis. Data showed that about
30 percent of ulcerative colitis patients used steroids. Among those that did, 15.8
percent had low bone-mineral density. Only 7.1 percent of non-steroid users had
low BMD. BMD is a risk factor for fragility fractures. Steroid users were nearly
twice as likely to have a fragility fracture.  (Journal of Clinical Endocrinology and
Metabolism, June 2013)
Two IBD medications reduce hospitalizations and surgeries — A study using
eight years of data from 176 VA facilities has found that treatment with inﬂiximab
and an immunomodulator reduces the one-year risk of hospitalization and surgery
in men with inﬂammatory bowel disease. The study was done by researchers at
the Houston VA, in conjunction with university scientists. It included data on
more than 20,000 men with either Crohn’s disease or ulcerative colitis. Those who
received nine months of dual-drug therapy had a 73 percent decreased risk of
hospitalization and a 92 percent decreased risk of surgery. Only about 1.5 percent
of Veterans in the study received dual-drug therapy. Inﬂiximab (trade name 
Remicade) has been approved for treating Crohn’s disease since 1998. It is also
approved to treat ulcerative colitis, rheumatoid arthritis and other conditions. 
Immunomodulators aﬀect the immune system, either by boosting it or suppressing
it, in order to help treat disease.  (Clinical Gastroenterology and Hepatology, 
October 2013)
Proton-pump inhibitors work equally well in the obese — People who are
obese are more likely to have heartburn, or gastroesophageal reﬂux disease
(GERD). However, treatment with proton-pump inhibitors works just as well in
obese patients as in normal-weight ones. A study of patients treated at the
Kansas City (Mo.) VA and the University of Kansas showed that weight was not 
a factor in the success of treatment with esomeprazole. People who were obese
before treatment did tend to have more severe reﬂux symptoms, however. 
(Journal of Clinical Gastroenterology, September 2013)
Gastrointestinal Health
Facts about 
Gastrointestinal Health
• Gastrointestinal disorders aﬀect
people of all ages. More than 
1 million Americans suﬀer from 
inﬂammatory bowel disease (IBD),
a term that includes Crohn’s 
disease and ulcerative colitis. 
• Both Crohn’s disease and 
ulcerative colitis have increased 
in Veterans between 1998 and
2009. Meanwhile, in the general 
population, the diseases have 
become less common.
• IBD is more common in whites
and in younger people; most people
are diagnosed before age 30. 
• Frequent heartburn, or 
gastroesophageal reﬂux disease
(GERD), is even more common than
IBD. About 1 in 10 Americans 
experiences GERD symptoms at
least once a week. Smoking and
obesity can contribute to GERD
symptoms, and many foods—
particularly fatty, fried, citrus- or
tomato-based foods, chocolate,
and caﬀeine—can worsen symptoms.
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VA Research is conducting a
wide array of studies to better
understand and treat the ill-
nesses experienced by many
Veterans of the 1990–1991 Gulf
War.  The efforts are guided 
by a Strategic Plan for Gulf
War Research, developed with
input from researchers, physi-
cians, and Veterans themselves.
The plan is reviewed annually
to make sure it incorporates the
latest emerging knowledge.
Gulf War
Recent Advances 
Biorepository brain bank to help research — The Gulf War Veterans' Illnesses
Biorepository is seeking Veterans from the 1990-91 Gulf War era who would like
to participate in research about conditions aﬀecting Gulf War Veterans. Based at
the Southern Arizona VA and also involving VA researchers in Boston, the bank
collects, processes, and stores specimens and health information and provides the
materials to authorized researchers for scientiﬁc studies. Veterans who enroll
complete surveys about their health every six months to a year, and upon 
their death, donate their brain and in some cases other body tissue for future 
research on Gulf War Veterans’ illnesses.
(www.research.va.gov/programs/tissue_banking/gwvib)
Brain changes after chemical exposures — Durham VA researchers have
shown that exposure to Gulf War-related chemicals causes mood changes and
memory problems. Researchers used a rodent model of Gulf War illness. The 
behavior changes were linked with changes in the volume of the brain’s 
hippocampus, as well as loss of neurons, reduction in the creation of new neurons,
and inﬂammation. The chemicals tested included permethrin, DEET, and 
pyridostigmine bromide. The ﬁrst two chemicals are pesticides. The third is
meant to protect against the eﬀects of nerve gas. The authors note that anti-
inﬂammatory treatments, as well as treatments that encourage neuron growth,
may help with Gulf War illness symptoms.  (Neuropsychopharmacology, November
2013)
Few long-term eﬀects of depleted-uranium exposure — Some Gulf War 
Veterans were exposed to depleted uranium through friendly-ﬁre incidents.
Exposures included wound contamination with uranium particles, inhalation of
particles, and uranium metal fragments embedded in tissue. These Veterans have
been surveyed every other year, and show elevated uranium levels in urine. But
after 20 years, few uranium-related health eﬀects have been seen. A report by 
researchers at the Baltimore VA focused on kidney and lung health in this group.
Uranium exposure had minimal eﬀects on the kidneys, but some Veterans did
show reduced kidney function from exposure to multiple metals. Lung function
in this group of Veterans remained normal. (Health and Physiology, April 2013) 
Gulf War
Facts about 
Gulf War Veterans’ Illnesses
• Nearly 700,000 U.S. troops served
in the 1990-1991 Gulf War.
• At least a quarter continue to 
report troubling health symptoms.
The majority have what VA terms
“medically unexplained chronic
multisymptom illness.” 
• Others are considered to 
have chronic fatigue syndrome, 
ﬁbromyalgia, functional 
gastrointestinal disorders, 
or undiagnosed illnesses.
• Exposures during the war 
included pesticides, vaccines, oil
well ﬁres, sarin gas, pyridostigmine
bromide (to protect against sarin
gas), depleted uranium, chemical
and biological weapons, noise,
sand, and extreme heat.
• Research has found brain 
diﬀerences in those with 
symptoms of Gulf War Veterans’ 
illnesses. However, exact causes
and reliable treatments are still
being sought. 
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VA research addresses the 
challenges posed by the health
care needs of diverse popula-
tions and the disparities that
arise in care delivery, access,
quality, and outcomes. VA aims
to understand the reasons for
healthcare disparities, develop
interventions to reduce them,
and translate findings into
practice. Studies address 
multiple ethnic and racial
groups, as well as disparities
due to income, age, sex, and
other factors. System-level 
disparities are also investigated. 
Health Care Disparities
Recent Advances 
Racial disparities persist for hip, knee replacements — Birmingham 
VA researchers analyzed 18 years of Medicare data on hip and knee replacements
in Caucasians and African Americans. In 1991, knee replacement surgery was 
36 percent less common in African Americans. By 2008, it was 40 percent less
common. Disparities in 30-day hospital readmission increased even more sharply.
The study did not focus on why knee replacement might be less common in
African Americans, nor why outcomes seemed to be worse. (Annals of the 
Rheumatic Diseases, online Sept. 18, 2013)
Females have higher melanoma survival rates — Among white adolescents
and adults, females have higher survival rates after treatment for melanoma (skin
cancer), according to a study from the Palo Alto VA. The study included 26,107
people who were followed for an average of 7 ½ years. Adolescent males and
young-adult males were 55 percent more likely to die of melanoma than females
of the same ages. Researchers controlled for the location of the cancer, thickness
of the tumor, and whether and how far it had spread. They also controlled for
health insurance status and income. Previous studies have found similar diﬀerences
in older people, but those diﬀerences were attributed to earlier diagnosis in 
females.  (JAMA Dermatology, August 2013)
Racial disparities found in older Americans on antidepressants — Ann Arbor
VA researchers showed that older African American women are less likely than
white women to take their prescribed antidepressants. Researchers followed
nearly 200 people, all ages 60 and older. All were diagnosed with depression and
recommended for antidepressant medication by their primary-care doctors. After
four months, 44 percent of African American women were taking the medication,
compared with 74 percent of white women. The gap was smaller between
African American and white men.  According to the Centers for Disease Control
and Prevention, African Americans are more likely than whites to have depression.
Other studies have shown that whites are more likely to be prescribed 
antidepressants and more likely to use them. (American Journal of Geriatric 
Psychiatry, October 2013) 
Health Care Disparities
Facts about Health Care
Disparities
• Health care disparities exist in a
range of settings in the United
States. They include disparities by
race or ethnicity, age, income, sex,
and other characteristics. 
• Disparities have multiple origins,
including but not limited to access
barriers, communication issues,
cultural factors, economics, genetics,
and lifestyle factors. Research 
suggests that reducing these 
disparities will require not only 
improving equity within the health
care system, but also extending 
beyond the system and into the
communities where patients live
and work. 
• VA has traditionally been at the
forefront of research in reducing
disparities, and is uniquely suited
for such study, given its integrated
health care system that provides
universal access for Veterans. 
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VA researchers are studying 
ways to prevent, diagnose, and 
treat hearing loss, addressing 
a wide range of technological, 
medical, rehabilitative, and 
social issues. Much of the work
takes place at the National 
Center for Rehabilitative 
Auditory Research (NCRAR) 
in Portland, Ore. 
(www.ncrar.research.va.gov). 
Hearing Loss
Recent Advances 
Working toward tests for tinnitus — Tinnitus (ringing in the ears) is common 
in Veterans, but there are no objective tests to diagnose it. Researchers at the
NCRAR conducted three phases of testing to try to distinguish Veterans with 
tinnitus from those without. They found some diﬀerences between the groups,
but no single test or series of tests could reliably diagnose the condition. As many
as 4 million Veterans have tinnitus, with 1 million seeking treatment for it.  Future
research may help researchers understand how to diagnose tinnitus, which also
could lead to better treatments.  (Journal of Rehabilitation Research and 
Development, Vol. 50, No. 4, 2013)
Group hearing-aid ﬁttings eﬀective, less costly — This study randomized 644
people to attend either group or individual visits for hearing aid ﬁttings and follow-
up. There were no diﬀerences in how well the hearing aids performed, or how
often they were worn. However, group visits cost about half of what individual
visits cost. Puget Sound (Wash.) VA researchers did note that those who had
group visits were more likely to wish they had more one-on-one time with an 
audiologist. However, those who had group visits said they gained support and
insight from other patients during the visits. Group results could reduce costs
while providing community support for patients with hearing loss.  (Journal of 
Rehabilitation Research and Development, Vol. 50, No. 4, 2013)
Frequency modulator helps with understanding speech — A recently 
completed study shows that frequency modulation (FM) may help Veterans who
have normal hearing but problems understanding speech, due to mild traumatic
brain injury. The study tested an FM system, which uses radio waves to transmit
signals directly from a microphone to an earpiece to make a speaker’s voice
clearer. It also tested a “brain-training” computer program that has users follow
instructions or interpret sounds. Preliminary results showed improved outcomes
among those using FM. Researchers at NCRAR and the Tampa VA are continuing
to analyze data. ("Evaluation of approaches to auditory rehabilitation for mild 
traumatic brain injury," www.ncrar.research.va.gov)
Hearing Loss
Facts about 
Hearing Loss
• Hearing loss aﬀects some 28 
million Americans, including more
than half of those over age 75. 
• The most common cause of hear-
ing loss is exposure to harmful levels
of noise. Other possible causes 
include allergies, infections, drugs,
and genetic factors. 
• Some hearing loss can be reversed
through surgery or medication. 
In other cases, hearing loss is 
permanent but can be reduced
through the use of hearing aids.
Though almost all people with
hearing loss could be helped by
hearing aids, only about one in 
ﬁve uses them. 
• Increasingly, Veterans score 
normally on a hearing test but
have diﬃculty understanding
speech. This condition, called 
auditory processing disorder, often
is associated with blast exposure.
• Noise-induced hearing loss and
tinnitus are among the most com-
mon disabilities aﬀecting Veterans. 
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VA research on hepatitis C 
includes clinical trials of 
treatments, epidemiologic 
studies, investigations into 
the biological mechanisms of
infection, and studies on 
removing barriers to treatment.
Hepatitis C
Recent Advances 
Interferon-alpha treatment failure may indicate risk for cirrhosis — People
with hepatitis C who do not respond to treatment with interferon have a higher
risk of cirrhosis than other patients, says a study from the San Francisco VA. The
study included Veterans as well as patients at a university hospital. Those who
failed interferon treatment had a higher cirrhosis risk than three other groups:
those receiving no treatment, those who responded to interferon treatment, and
those who responded but then relapsed. However, survival rates were the same
for non-responders as for patients who received no treatment. Patients had been
followed for 7 to 10 years. Cirrhosis is irreversible scarring of liver tissue. Common
causes are hepatitis and alcoholism.  (PLoS One, 2013)
Treatment beneﬁts patients with anemia — A study of 200,139 Veterans with
hepatitis C showed that those with anemia beneﬁt from treatment. Treatment 
reduced their risk of mortality by more than half.  Generally, treatment is oﬀered
less frequently to people with anemia, because low red blood-cell count is a
common side eﬀect. However, given that treatment appears to improve survival,
the authors suggest identifying and treating hepatitis C patients who have anemia.
(Clinical Gastroenterology and Hepatology, June 2013)
Trial tests solution to overcoming treatment barriers — Most people with
hepatitis C are not treated for it, often because of mental health issues or substance
abuse. A multisite trial is under way to increase treatment rates among Veterans.
The study has randomized 364 VA patients to either integrated care or usual care.
Those receiving integrated care meet with a mental health provider, who addresses
risk factors, consults with treatment providers, and manages care before and 
during treatment. The study will focus on treatment initiation and completion
rates, as well as viral response to treatment. Researchers also will collect data on
depression, substance use, PTSD symptoms, quality of life, and health care 
satisfaction. Each patient will be followed for 22 months.  (Contemporary Clinical
Trials, July 2013)
Hepatitis C
Facts about Hepatitis C
• Hepatitis C is caused by a virus.
The disease is spread through 
contact with infected blood or 
contaminated IV needles, razors,
tattoo tools, or other items. 
• Hepatitis C is more common
among Veterans than the general
population. About ﬁve percent of
Veterans treated in the VA health
care system have hepatitis C, 
compared with two percent of 
non-Veterans.
• Most people with hepatitis C 
do not have any signs or symptoms
of the disease for decades. By the
time the disease is diagnosed,
there can be signiﬁcant damage to
the liver, leading to complications
such as cirrhosis and liver cancer,
and sometimes resulting in death. 
• Treatment can be eﬀective, but
the regimen is diﬃcult. It can take
a year of treatment before the
body completely clears the virus,
and the drugs to treat hepatitis C
can cause fatigue, depression, 
anemia and skin rashes. 
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VA research on homelessness
looks at causes, risks, and 
prevention, and helps develop
interventions to improve health
and provide resources and
training. The National Call
Center for Homeless Veterans 
(1-877-4AID-VET) is staffed 
by trained responders who
provide support and resources
to Veterans and their families
who lack secure housing. In
2012, the center handled more
than 80,000 calls.  
Homelessness
Recent Advances 
Violence, trauma common among homeless— VA’s National Center for PTSD
published two recent studies that focused on trauma in homeless Veterans. In
one study of 115 people, 82 percent had experienced interpersonal violence as
adults, and 62 had experienced it as children. Also, 53 percent experienced highly
stressful events during military service.  Another study included more than
126,000 homeless Veterans who used VA health care in 2010. Of these, 40 percent
of female Veterans and 3 percent of males had experienced sexual trauma while
enlisted. These numbers are higher than those in the general Veteran population.
A study by the New England VA Mental Illness, Research, Education and Clinical
Center also found homelessness associated with childhood problems, such as
abuse and family instability.  (Journal of General Internal Medicine, July 2013; 
Military Medicine, September 2013; Social Psychiatry and Psychiatric Epidemiology,
March 2013)
Dental care boosts success rates —Dental care ranks in the homeless Veteran’s
top three unmet needs, along with housing and child care. Several VA centers 
examined the impact of dental care on homeless Veterans discharged from a 
VA transitional housing intervention program. The study included 9,870 Veterans.
Of these, 4,482 received dental care during the program. Compared with those
not receiving dental care, they were 30 percent more likely to complete the 
program, 14 percent more likely to be employed or ﬁnancially stable, and 
15 percent more likely to have found residential housing.  (American Journal of
Public Health, online May 16, 2013)
Incarceration history no barrier to ﬁnding housing — There is concern that
Veterans with a history of incarceration are at a particular disadvantage in 
exiting homelessness.  However, a study by the New England VA Mental Illness, 
Research, Education and Clinical Center suggests incarceration is not a major
barrier.  Researchers studied 14,557 Veterans who were part of the Housing 
and Urban Development-Veterans Aﬀairs Supportive Housing program. Overall,
a history of incarceration, reported by about 65 percent of the Veterans, did not
appear to aﬀect progression through the program or the chances of obtaining
housing.  (Community Mental Health Journal, online June 1, 2013)
Homelessness
Facts about 
Homelessness
• Veterans are at higher risk for
homelessness than the general
population. The risk of becoming
homeless is particularly high in
Veterans who live in poverty:
about 10 percent of these Veterans
are homeless in any given year.  
• Since 2009, the number of 
homeless Veterans has dropped
more than 17 percent. The federal
government aims to end 
homelessness among Veterans 
by 2015 through the Homeless 
Veterans Outreach Initiative. 
• VA and the Department of 
Housing and Urban Development
jointly administer a program that
provides permanent housing and
ongoing case management.
• The National Center on 
Homelessness Among Veterans 
oﬀers preventive services, housing
support services, treatment 
resources, and job training. 
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One of the earliest contributions
of VA researchers to medical
science was the establishment
of effective treatments for 
tuberculosis. Since then, 
VA scientists have helped 
advance the understanding,
prevention, and treatment of
numerous infectious diseases,
ranging from the common cold
to major public health threats,
such as AIDS and influenza.
Research also focuses on 
infectious diseases that may
put U.S. troops abroad at risk,
such as malaria and 
leishmaniasis.
Infectious Diseases
Recent Advances 
Copper reduces hospital-acquired infections —Copper-alloy surfaces in 
intensive care units (ICUs) harbor fewer bacteria that cause hospital-acquired 
infections. Researchers from the Ralph A. Johnson VA Medical Center (Charleston,
S.C.) did the study in association with the University of South Carolina and 
Memorial Sloan-Kettering Cancer Center, New York. The study involved 650 
patients admitted to the ICU. They were randomly assigned to either a room with
copper-alloy surfaces or one without. Six objects in each room were sampled
weekly for bacteria. Patients were monitored for infections during hospitalization
and for six months afterward. About 13 percent of people in non-copper rooms
developed an infection or became colonized with infective bacteria, compared
with 7 percent of those in copper-alloy rooms. This was a pilot study, and 
researchers suggest larger, follow-up studies.  (Infection Control and Hospital 
Epidemiology, May 2013)
Potential new antimalarial drug — Researchers at the Portland VA have 
identiﬁed a new potential drug to ﬁght malaria. ELQ-300 is highly active against
malaria parasites in rodent models. It is predicted to need a low dose in patients,
and has a long half-life. ELQ-300 targets both the liver stage and the blood stage
of the malaria parasite. It is in a new class of antimalarial drugs called 
quinolone-3-diarylethers.  (Science Translational Medicine, March 20, 2013)
Outpatient clinics one source of C diﬀ — Clostridium diﬃcile (C diﬀ) infection
can cause diarrhea and intestinal inﬂammation. The bacterium is common in
long-term care facilities, and infection is often associated with taking antibiotics.
C diﬀ infections have become more severe and frequent in the past several years.
Cleveland VA researchers followed 67 people diagnosed with C diﬀ infections.
Many had one or more outpatient visits during the 12 weeks after diagnosis.
About one-third had C diﬀ on their skin during an outpatient visit, and 
27 percent spread C diﬀ to surfaces in the outpatient clinic. Other studies have
found that even four weeks after antibiotic treatment, half of C diﬀ patients 
can still spread the bacteria.  (PLoS ONE, July 2013) 
Infectious Diseases
Facts about Infectious 
Diseases
• Infectious diseases are generally
classiﬁed according to the source
of the infection. The major types
are viral, bacterial, parasitic, and
fungal. 
• In the VA health care system, two
viral diseases of special concern are
HIV/AIDS and hepatitis C. 
VA maintains special websites 
devoted to these conditions:
www.hiv.va.gov and 
www. hepatitis.va.gov. 
• VA investigators are studying
these and a range of other 
infectious diseases, working 
toward developing eﬀective new
preventive strategies, vaccines,
and drugs. 
• Hospital-acquired infections are
an increasing concern, causing
nearly 100,000 deaths every year in
the U.S. and leading to some $40
billion in health care costs.
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VA has a comprehensive 
research portfolio aimed at
preventing and improving the
treatment of chronic kidney
disease. There are many causes
of chronic kidney disease, 
but the two main causes—
accounting for up to two-thirds
of cases—are diabetes and high
blood pressure. Research on
these related illnesses may also
help reduce the prevalence of
chronic kidney disease among
Veterans. 
Kidney Disease
Recent Advances 
Drug works in kidney patients with heart failure — Enalapril reduces the risks
of hospitalization and death in people with kidney disease who also have heart
failure. The Studies of Left Ventricular Dysfunction (SOLVD) Trial, based at the
Birmingham (Ala.) VA, included 2,569 heart failure patients. Of these patients,
1,036 had chronic kidney disease. All were randomized to receive enalapril or
placebo. In kidney-disease patients, enalapril reduced the risk of hospitalization
by 23 percent and the risk of death by 12 percent. In those without kidney 
disease, these risks were reduced by 20 percent and 18 percent, respectively.   
(International Journal of Cardiology, July 15, 2013)
Improving survival through depression treatment — Researchers at the 
VA North Texas Health Care System, Dallas, have started a randomized, placebo-
controlled, double-blind trial of sertraline, an antidepressant. The trial will enroll
200 adults with kidney disease and major depression. The primary outcome is
improvement in depression symptoms. One in ﬁve patients with kidney disease
also has major depression. These patients are at increased risk for hospitalization
and death. However, depression is still underdiagnosed and undertreated in 
kidney disease patients.  (Contemporary Clinical Trials, January 2013)
Lowered enzyme activity linked with early kidney disease — Inducing the 
activity of the enzyme AMPK reverses kidney damage in the early stages of 
kidney disease, according to studies done in a rodent model at the San Diego 
VA and the University of California, San Diego. AMPK is normally protective of the
kidneys. But in a commonly used rodent model, early kidney damage leads to 
reduced amounts of AMPK. When researchers upped the activity of AMPK, kidney
function improved and kidney damage lessened. Restoring or inducing AMPK 
activity may be one way to treat kidney disease, the authors suggest.  They note
that their approach would be speciﬁc to kidney disease that does not result as a
complication of diabetes. (American Journal of Physiology – Renal Physiology, 
September 2013)
Kidney Disease
Facts about 
Kidney Disease
• The kidneys are a pair of ﬁst-
sized organs located on either side
of the spinal column. Kidneys 
perform life-sustaining functions
that keep the rest of the body in
balance.
• Early kidney disease has few
symptoms. As it worsens, 
complications such as high blood
pressure, arteriosclerosis, anemia,
weak bones, and nerve damage
can develop. If the disease pro-
gresses to kidney failure, dialysis or
a kidney transplant is needed. 
• About 10,000 Veterans are on
dialysis. Each year, 3,200 Veterans
are diagnosed with kidney failure.
• In partnership with the 
University of Michigan, VA 
established a registry in 2012 
to help care for Veterans with 
kidney disease.
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Major areas of focus for 
VA research on mental health
include substance abuse, 
posttraumatic stress disorder,
adjustment and anxiety 
disorders, depression, bipolar
disorder, and schizophrenia.
Researchers are seeking 
biomarkers for diagnosis 
and treatment, studying and
testing new drug therapies,
and improving access to 
mental health care through
telehealth and other 
innovative approaches.
Mental Health
Recent Advances 
Too much, too little sleep may indicate poor mental health — A study of
OEF/OIF Veterans has found that those who sleep too much or too little are more
apt to have depression or PTSD. Durham VA researchers studied 1,640 Veterans
with an average age of 37. Those who slept ﬁve or fewer hours or nine or more
hours were more likely to have major depressive disorder or PTSD. Assessing
sleep problems may help clinicians identify and treat Veterans at risk for mental
health issues.  (Sleep, July 2013)
Most older Veterans resilient after traumas — Even when faced with multiple
traumas, about 7 in 10 older Veterans are considered resilient, with low levels of
psychological distress.  A study from the West Haven (Conn.) VA included 2,025
Veterans age 60 and older. About 60 percent had low levels of lifetime trauma,
and 40 percent had higher levels. Those with higher levels were more likely to be
resilient if they had at least a college education and were married or partnered.
Resilient Veterans also had strong social supports and fewer physical diﬃculties,
felt integrated into their communities, and felt a sense of purpose in life.  
(Depression and Anxiety, May 2013)
Pain more common with mental-health conditions — Veterans with 
depression, schizophrenia, and bipolar disorder are more likely to also have pain,
according to research from the Ann Arbor VA. The study analyzed treatment
records from nearly 5.2 million Veterans who received VA care in 2008. Veterans
with depression were 2 ½ times as likely to have pain. Those with bipolar disorder
were about twice as likely, and those with schizophrenia had a 20 percent 
increased risk of pain. The most common types of pain were general chronic pain
and headache. The researchers suggest further study on how pain might aﬀect
mental health treatment, as well as barriers to eﬀective pain treatment in people
with mental health conditions. (General Hospital Psychiatry, Sept-Oct 2013) 
Mental Health
Facts about 
Mental Health
• Mental health conditions such as
depression and anxiety are common
in the United States, with more than
a quarter of Americans suﬀering
from a diagnosable mental disorder
in any given year.
• Mental health is a major focus 
for VA’s health care system. About
30 percent of Iraq and Afghanistan
Veterans will be diagnosed with a
mental health condition. PTSD 
and depression are common, with
about 18.5 percent of these 
Veterans having at least one of
these diagnoses.  
• In addition to deployment-related
mental health problems, 
schizophrenia is a major focus of
VA clinical care and research, 
aﬀecting some 100,000 VA patients
and accounting for nearly 12 percent
of VA’s total health care costs.
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VA research on obesity 
examines the biological 
mechanisms of weight gain
and weight loss; compares the
safety and effectiveness of 
obesity treatments; and aims to
identify strategies to prevent
weight gain through exercise
and healthy eating. These 
efforts complement VA’s
“MOVE!” program, a national
weight-management and 
exercise program designed and
coordinated by the VA National
Center for Health Promotion
and Disease Prevention.
Obesity
Recent Advances 
Videoconferencing as an aid to weight management — VA researchers in
Sioux Falls, S.D., studied the weight-loss outcomes among 120 Veterans, 
half of whom took part in a series of 12 weekly MOVE! classes delivered via 
videoconferencing. The MOVE! participants lost weight while the control
group—which took part in no video or in-person classes—gained weight. The 
average weight diﬀerence between the groups was about 12 pounds. The weight
loss was sustained among the MOVE! participants at one year after the initial
baseline measurements. The authors say videoconferencing shows great promise
as a way to deliver VA’s successful MOVE! program, especially for Veterans who
live in remote areas or otherwise can’t make it to VA sites where the program is
oﬀered.  (Journal of Rural Health, online Sept. 24, 2013)
Weight loss reduces reﬂux — Weight loss can reduce or eliminate the 
symptoms of gastroesophageal reﬂux disease (GERD), according to a study 
from the Kansas City (Mo.) VAMC. Researchers enrolled 332 people in a six-month
weight-loss program. The average weight at the start of the study was 222
pounds. After six months, it had dropped to about 193 pounds. The percentage
of people with GERD symptoms dropped from 37 percent to 15 percent. More
than 80 percent of people had at least some improvement in GERD symptoms, if
not complete resolution.  (Obesity, February 2013)
Gastric banding helps type 2 diabetes — A two-year study found that gastric
banding nearly always improves or eliminates diabetes symptoms. San Diego
VAMC researchers followed 66 people with type 2 diabetes who had gastric
banding, a type of obesity surgery. Before the banding, all required daily medica-
tion for their diabetes. After two years, 48.5 percent had no symptoms of dia-
betes. Another 47 percent had improvement of symptoms. Only 4.5 percent had
no change in their diabetes status. People with no change were more likely to
have had diabetes for a longer time period before the procedure. They were also
likely to have lost less weight over the two-year time period. (Postgraduate 
Medicine, November 2012)
Obesity
Facts about Obesity
• Obesity is deﬁned as a body mass
index (BMI) of 30 or greater, while
overweight is deﬁned as a BMI of
25–25.9. 
• More than 35 percent of American
adults are obese. About 17 percent
of children are obese. That trans-
lates to more than 78 million adults
and 12.5 million children.
• The cost of obesity in the United
States is estimated at $147 billion
per year.
• Obesity is a risk factor for heart
disease, diabetes, stroke, and some
types of cancer.
• More than 7 in 10 Veterans 
who receive VA care are either
overweight or obese. 
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VA is working to develop new
approaches to alleviate 
Veterans’ pain, which may 
result from spinal cord injury,
burns, amputations, traumatic
brain injury, cancer, arthritis,
or other conditions. 
VA’s research portfolio in this
area covers a wide range of
topics, from drug discovery to
alternative treatments, such as
yoga or massage. 
VA investigators are also 
leaders in studying the impact
of pain on daily function and
quality of life.  
Pain Management
Recent Advances 
Walking for pain relief — Online information and social support may help 
Veterans stick with a walking program, at least in the short term. A study at the
Ann Arbor VA included 229 Veterans with chronic back pain. All received a pe-
dometer and could upload its data to a computer. About half also had access 
to a website that provided automated walking goals, feedback, motivational
messages, and social support. After six months, this group reported signiﬁcantly
less back pain than the pedometer-only group. However, after 12 months, there
were no diﬀerences between the groups. The authors suggest further interven-
tions might help to support improvement beyond six months. (Journal of Medical
Internet Research, August 2013)
SCOPE: Optimizing pain management — The Indianapolis VA recently 
began the Stepped Care to Optimize Pain care Eﬀectiveness (SCOPE) study, 
a randomized clinical trial in ﬁve primary care clinics. Started in 2009, the study
includes 250 Veterans with persistent musculoskeletal pain. They are randomized
to usual care or stepped care. Stepped care combines automated symptom 
monitoring with a telephone-based, pain specialist team to treat pain. Veterans
will be assessed at the start of the study and after 1, 3, 6, and 12 months. SCOPE
aims to overcome common barriers to eﬀective pain treatment, which include 
inadequate initial treatment, failure to monitor adherence and symptom 
response, and failure to adjust treatment over time. (Contemporary Clinical Trials,
March 2013)
Vitamin D supplements improve pain, sleep — Vitamin D supplements reduce
pain and improve sleep, according to a small study from the Atlanta VA. Twenty-
eight Veterans were enrolled in the study. All had multiple areas of chronic pain,
as well as low blood vitamin D levels (<30 ng/ml). They took vitamin D supple-
ments for over a year. Their pain decreased, sleep time and quality increased, and
general health and social functioning increased. Vitamin D is a fat-soluble vitamin
that supports the body’s absorption of calcium and phosphorus. It is crucial for
bone growth, cell growth, and immune system strength. (Clinical Journal of Pain,
April 2013) 
Pain Management
Facts about Pain
• Pain is one of the most common
reasons people consult a physician
and is cited as the most common
symptom in service members 
returning from combat. 
• About half of VA patients are 
diagnosed with at least one type 
of chronic pain. 
• Some types of chronic pain, 
such as the nerve pain experienced
by many people with spinal cord 
injury, are notoriously diﬃcult 
to treat. 
• VA’s Chronic Pain Rehabilitation
Program, established in 1988, 
is a nationally known center for
chronic pain research, 
treatment, and education
(www.tampa.va.gov/chronicpain).
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VA has six Centers of Excellence
focused on Parkinson’s disease,
based in Houston, Philadelphia,
Portland, Richmond, 
San Francisco, and Los Angeles
(www.parkinsons.va.gov). 
Researchers at these sites are
studying the biochemical 
pathways involving dopamine—
a brain chemical implicated 
in Parkinson’s disease—and 
testing a variety of treatment 
approaches, including 
medication, surgery, and 
electrical stimulation. 
Biomedical and clinical studies
on Parkinson’s disease are 
ongoing at many other 
VA sites, as well.
Parkinson’s Disease
Recent Advances 
Deep-brain stimulation does not increase risk of suicide — Questions have
been raised about suicide risk in people undergoing deep-brain stimulation
(DBS) for advanced Parkinson’s disease. At least one study has found an increased
risk. Philadelphia VA researchers randomized 255 Parkinson’s patients to either
DBS or medical (drug) therapy. A second phase of the study randomized 
299 patients to one of two types of DBS. In the ﬁrst part of the study, no suicide
or attempts were reported, and new thoughts of suicide were rare (1 to 2 percent
of patients) and not more common in the DBS group. In the second phase,
thoughts of suicide were also rare, and not diﬀerent between DBS groups.  
(Journal of Neurology, Neurosurgery, and Psychiatry, October 2013) 
APOE E4 linked with dementia — The E4 variant of the apolipoprotein-E (APOE)
gene has been linked with Parkinson’s in previous studies. It also is linked with
Alzheimer’s. Now, research from the Puget Sound (Wash.) VA has found that
APOE E4 is more common in people with dementia who have Parkinson’s,
Alzheimer’s, or Lewy body disease, another neurodegenerative disorder that
causes dementia. In genetic studies of donated brain tissue, APOE E4 was found
in 7 percent of people without dementia. It was found far more often in
Alzheimer’s patients with and without Lewy body disease, people with only 
Lewy body disease, and patients with Parkinson’s.  (JAMA Neurology, 
February 2013)
‘Forced’ exercise may not help Parkinson’s symptoms — “Forcing” patients to 
exercise using a motorized stationary bike does not appear to improve Parkinson’s
symptoms. A small study by the Richmond VA assigned 13 patients to exercise
and 10 patients to usual care. The exercise group used a stationary bicycle twice a
week for eight weeks. The bike had motorized pedals that could be programmed
to a set speed to allow users to move their legs without eﬀort. Researchers found
no diﬀerences in symptoms. Past studies have found beneﬁts to “forcing” 
Parkinson’s patients to exercise. Those studies used tandem bicycles, with the 
patient in the back seat. (Rehabilitation Research and Practice, 2013)
Parkinson’s Disease
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Facts about 
Parkinson’s Disease
• Parkinson’s disease is a 
disorder of the central nervous 
system, characterized by the 
death of dopamine-producing 
cells in the brain. 
• The disease causes a variety of
“motor” (related to movement of
the muscles) symptoms: rigidity 
of the muscles, delayed movement,
poor balance, tremors. 
• Non-motor symptoms of 
Parkinson’s include sleep 
disturbances, urinary dysfunction,
constipation, swallowing problems,
mood disorders, and cognitive
deﬁcits. 
• Parkinson’s aﬀects as many as 
1.5 million Americans, mostly 
people over age 50. About 80,000
Veterans have the condition.
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VA is working to develop safer,
more effective treatments
based on new knowledge about
the role of genes in health and
disease. The goal is to provide
medical care that is personalized
to the genetic makeup of 
individual Veterans. 
In early 2011, VA launched 
the Million Veteran Program 
(www.research.va.gov/mvp), 
a major initiative that aims to
build one of the world’s largest
databases of genetic, military
exposure, lifestyle, and health
information. 
Personalized Medicine
Recent Advances 
Gene variation boosts response to clopidogrel — Clopidogrel (sold as Plavix)
is a common blood thinner that is prescribed to prevent stroke and second heart
attacks. Researchers from the Baltimore VA have found that variations in the CES1
gene reﬂect how well a person breaks down and uses clopidogrel. They studied
DNA from 916 people taking the drug. Those who carried a gene variation called
CES1-143E had higher levels of metabolized clopidogrel in their bloodstreams.
These people also had blood that clotted less easily, showing that the drug was
doing its job. Other gene variations have been shown to aﬀect response to 
clopidogrel, but this is the ﬁrst study to focus on CES1-143E. Only 1 percent to 
2 percent of people carry this gene variation. This information may be used in the
future to better personalize treatment after a heart attack.  (Pharmacogenetics
and Genomics, January 2013)
Personalizing medicine choice in COPD patients — Chronic obstructive pul-
monary disease (COPD) increases the risk of heart failure. So does high blood
pressure. In Veterans with both of these conditions, which medicines are best for
lowering blood pressure? Researchers at the Puget Sound VA compared several
two-drug combinations prescribed to 7,104 Veterans between 2001 and 2006.
They found that in patients without existing heart failure, treatment that in-
cluded a thiazide diuretic was most eﬀective. In patients with heart failure, no
two-drug combination was more eﬀective than another.  (Chest, May 2013)
Gene linked to reduced risk of stroke — VA researchers in Baltimore looked 
at variations in a gene called ATP1A2 that might aﬀect the risk of stroke. One 
variation, rs2070704, was linked with a 26 percent lower risk of stroke. When 
researchers focused on ethnicity, they found the lower risk only in African 
Americans, and saw a stronger association in African American males than in 
females. Changes in ATP1A2 have been linked with a type of migraine. However,
the Baltimore researchers did not ﬁnd any links among migraine, stroke risk, and
ATP1A2. (Springerplus, 2013) 
Personalized Medicine
Facts about 
Personalized Medicine
• With the completion of the
Human Genome Project and other
gene-mapping eﬀorts, researchers
have a detailed map of humans’
genetic structure. Research is now
focused on learning more about
the role of speciﬁc genes, how they
interact, and what activates or 
deactivates them. 
• A common method of 
investigation is the “genome wide
association study,” or GWAS, in
which scientists scan and analyze
DNA from huge numbers of 
research volunteers to tease out
which genes or genetic variations
are linked to particular diseases 
or health traits. 
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VA supports numerous studies
aimed at understanding, 
treating, and preventing 
posttraumatic stress disorder
(PTSD). These studies range
from investigations of the 
genetic or biochemical under-
pinnings of the disease to 
evaluations of new or existing
treatments, including large
clinical trials. Much of the work
is conducted in collaboration
with the Department of 
Defense, and involves 
Veterans as well as active 
duty Service members. 
Posttraumatic Stress
Disorder
Recent Advances 
Brain protein linked with PTSD, hypervigilance — Lower levels of the 
norepinephrine transporter (NET) protein are found in people with PTSD, but not
healthy controls, according to a study by VA researchers in Connecticut. They
used positron emission tomography (PET) scans to look at the availability of NET
in a part of the brain called the locus coeruleus, which is involved with the body’s
response to stress. They scanned healthy adults, adults exposed to trauma who
did not develop PTSD, and adults exposed to trauma who developed PTSD. The
PTSD group had 41 percent lower availability of NET in this area of the brain than
healthy adults did. There was no signiﬁcant diﬀerence between the two trauma-
exposed groups, however. In the PTSD group, people with greater NET availability
had more severe hypervigilance symptoms.  (JAMA Psychiatry, online Nov. 1, 2013)
Family stress increases PTSD risk for those exposed to combat — Life and
family stress during deployment can increase the risk for PTSD by up to nine
times in Veterans who were exposed to combat, says a study from the Providence
(R.I.) VA. The research included 238 National Guard/Reserves members who 
completed surveys about four months post-deployment. PTSD was linked with
higher levels of combat exposure and life and family concerns, and lower levels
of post-deployment social support. Three percent of Veterans with high combat
exposure but low family concerns had PTSD, compared with 27 percent of 
Veterans with high combat exposure and high levels of family concerns.  
(Psychiatry Research, online Dec. 30, 2013)
Telemedicine treatment eﬀective, less costly — Using videoconferencing to
provide psychotherapy to Veterans in remote locations is less costly than in-person
treatment. A study from the Honolulu VA previously showed that videoconferences
were just as eﬀective as in-person therapy. The same group found that 
videoconferencing had lower total costs, compared with in-person therapy.
Videoconferencing expands the reach of PTSD treatment to Veterans who live in
geographically isolated or remote areas, from which it may be diﬃcult to access
face-to-face counseling services.  (Telemedicine Journal and E-health, October 2013)
Posttraumatic Stress 
Disorder
Facts about PTSD
• PTSD aﬀects many people who
experienced life-threatening
events, such as combat, terrorist 
attacks, or personal assaults. 
• Symptoms include ﬂashbacks,
nightmares, depression, and social
withdrawal, as well as physical
health changes. 
• Treatment often includes 
anti-anxiety drugs or other 
medications, along with 
counseling therapy.
• As many as 20 percent of
Iraq/Afghanistan Veterans are
thought to have PTSD. This 
compares with about 10 percent 
of Gulf War Veterans and 
30 percent of Vietnam Veterans.
• Overall, about 5.2 percent of
adults will have PTSD in a given
year. Women are about twice as
likely as men to develop it.
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VA has long been a world
leader in prosthetics research
and care, and is now in the
forefront of developing and
testing innovative prosthetic
devices, such as the DEKA Arm,
that take advantage of the 
latest advances in computer
and robotics technology. 
VA researchers are also 
studying the best ways to
match existing prosthetic 
devices to the needs of those
with limb loss, and testing 
new approaches to prevent
non-traumatic amputation 
and heal injured extremities. 
Prosthetics/Limb Loss
Recent Advances 
Look to the squid — A team at the Cleveland VA has created a prosthetic mate-
rial inspired by a squid’s beak. The material transitions from hard to soft, making
it ideal for use in prosthetics. Attaching rigid artiﬁcial limbs to soft skin can cause
discomfort, sores, and tissue damage. The team created the material using cellu-
lose scaﬀolding. Its stiﬀness depends on how long it is exposed to ultraviolet
light. The material also could be used in other biomedical settings, such as im-
planted blood-sugar monitors, chemotherapy ports, and electrodes.  (Journal of
the American Chemical Society, online March 26, 2013)
Leg muscles can “learn” to control prosthetics — Researchers at the Ann Arbor
VA have shown that people with lower-limb loss can use signals from their 
remaining limb muscles to control robotic prosthetics. Previous studies had
shown the promise of the technique in upper limbs, but not lower ones. 
Researchers asked volunteers to control an object on a computer screen using a
muscle on the front of the lower leg. Half of the volunteers had no limb loss. The
other half had lost part of a lower leg, either due to trauma or vascular problems.
Initially, the limb-loss group had poorer control. But after 20 attempts over a 
one-hour period, there were no diﬀerences between groups. This was the case
even in volunteers who had lost a limb more than 15 years previously.  (Journal of
Rehabilitation Research and Development, Vol. 50, No. 5, 2013)
Statin use lowers risk for limb loss — People with diabetes who take statins
have a reduced risk of lower-limb amputations, says a study from the Hines VA
(Ill.). The study included 83,953 patients, followed from 2004 to 2008. During 
that time, 217 needed a lower-limb amputation, and about another 11,500 died. 
People who took statins were 35 percent less likely to experience an amputation,
and 43 percent less likely to die. Other cholesterol-lowering medications appeared
to reduce the risk of death by a similar amount, but did not reduce the risk of 
amputation. (Journal of Vascular Surgery, online Aug. 7, 2013)
Prosthetics/Limb Loss
Facts about
Prosthetics and Limb Loss
• More than 1,700 OEF/OIF Service
men and women suﬀered limb loss
between 2001 and 2012. Many of
these men and women are now in
care in the VA system, along with
Veterans of previous eras who 
suﬀered limb loss. 
• Aside from combat injuries, 
complications of diabetes are an-
other major cause of amputations:
In the U.S., people with diabetes
account for about two-thirds of all
lower-limb amputations. 
• Some of the nation’s leading
work on prosthetics and limb loss
takes place at centers of excellence
funded by VA’s Rehabilitation 
Research and Development Service.
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VA researchers are studying
the biological processes 
involved in spinal cord injury
(SCI), and working to develop
better treatments and adaptive
technologies. They are also 
addressing SCI complications
such as respiratory problems,
pressure ulcers, digestive 
complications, and circulatory
problems.
Spinal Cord Injury
Recent Advances 
Neuroprosthetics trial nearing end — A 10-year trial, set to end in 2015, is test-
ing a surgically implanted electrical stimulation system in people with SCI. During
the surgery, electrodes are implanted in muscles of the trunk and legs and leads are
connected to a stimulator/telemeter. By stimulating muscles, the system activates
muscles to allow for standing, better balance, and exercise. Patients are given
functional training and rehabilitation using the stimulation system, and are 
prescribed a course of exercise. Lab tests focus on strength, balance, and abilities
with and without the system. A preliminary study found improved quality of life
in patients using the system. The trial is taking place at the Louis Stokes Cleveland
VAMC and MetroHealth System, Cleveland. It is sponsored by VA, Case Western
Reserve University, and the National Institutes of Health.  (ClinicalTrials.gov; 
Journal of Rehabilitation Research and Development, Vol. 49, No. 2, 2012)
Employment support — VA researchers in Tampa and ﬁve other cities are 
studying a program called Individualized Placement and Support (IPS), designed
to help Veterans with SCI get back into the workforce. The program uses a team 
approach that includes vocational rehabilitation specialists working alongside
clinical care providers. More than 1,000 Veterans with SCI will be part of the trial,
about a ﬁfth of whom will be IPS participants; the others will receive usual care.
Researchers will compare outcomes across both groups, with the main goal
being long-term, stable, competitive employment.  (VA Research Currents, August
2013)
ReWalk ‘exoskeleton’ allows for standing, walking — Researchers at the Bronx
VA are evaluating Israeli technology that allows paraplegics to stand, walk, and
climb stairs. Nine participants have tested the ReWalk, which involves special
shoes, leg braces, a watch-like control pad, and a battery-ﬁlled backpack. On their
ﬁrst day using ReWalk, most people can stand and take a few steps. People in the
study have lost fat tissue, had improved bowel function and reduced diabetes
symptoms. One study participant has begun to regain feeling in his legs. The
$60,000 unit is under review by the Food and Drug Administration. (Bronx VA
Medical Center media advisory, March 2013)
Spinal Cord Injury
Facts about 
Spinal Cord Injury
• Spinal cord injuries impair the
brain’s ability to send messages to
the rest of the body. These injuries
can result in paralysis, loss of feeling,
chronic pain, and other serious
medical problems. 
• Spinal cord injuries are 
estimated to aﬀect as many as
332,000 Americans, with about
12,000 new injuries occurring each
year. About 81 percent of people
with these injuries are male.
• Nearly half of all injuries occur 
in people between the ages of 
16 and 30, so many patients live
with the eﬀects of these injuries 
for decades. 
• VA treats more than 26,000 
people with spinal cord injuries
and disorders each year, making it
the largest integrated health care
system in the world providing
spinal cord care.
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A leader in the field of 
addiction research for decades, 
VA continues to support a
broad portfolio examining 
substance abuse prevention,
screening and treatment, 
including studies aimed at 
understanding the genetic 
factors that may predispose
people to alcohol or drug abuse
and addiction. 
Substance Use 
Disorders
Recent Advances 
Primary care treatment is eﬀective — A 26-week primary care intervention is
just as eﬀective as specialty outpatient treatment for alcohol dependence, says a
study. The Philadelphia VA study enrolled 163 Veterans and randomly assigned
them to primary care treatment or specialty treatment. The primary care treatment
used medicine and psychosocial support. It was delivered in person or by phone.
Veterans in the primary care treatment were more than ﬁve times as likely as those
in specialty treatment to complete all 26 weeks. Overall abstinence rates were the
same between groups, and the primary care group had a smaller percentage of
days with heavy drinking. Primary care treatment for alcohol dependence may be
accessible to a larger percentage of people than specialty treatment. (Journal of
General Internal Medicine, online Sept. 20, 2013)
Vaccine for meth addiction — A vaccine for methamphetamine addiction is 
eﬀective and safe in a mouse model. Researchers at the Houston VA gave mice
three doses of the vaccine. Four weeks after the second dose, vaccinated and
non-vaccinated mice were tested with diﬀerent methamphetamine amounts.
Non-vaccinated mice showed changes in their movement patterns that could 
be attributed to meth addiction. Vaccinated mice showed much less of an eﬀect.
They also did not develop a positive conditioned response to receiving 
methamphetamine, whereas non-vaccinated mice did become conditioned.
(Drug and Alcohol Dependence, April 2013)
Gene linked with cannabis dependence — A study from the New Haven
(Conn.) VA has identiﬁed a gene variant that is linked with cannabis dependence
in African Americans. The researchers used a genome-wide association study, or
GWAS, to analyze DNA from 384 African American families and 354 European
American families. On the NRG1 gene, researchers found one area—rs17664708—
that was linked with cannabis dependence in both groups. The link was stronger in
African Americans, and the researchers replicated the results in another group of
African American study volunteers. They could not replicate the results in European
Americans. African Americans who had rs17664708 were nearly three times as
likely to exhibit cannabis dependence. (Biological Psychiatry, October 2012)
Substance Use Disorders
Facts about Substance Use
Disorders
• Substance use disorders include
dependencies on alcohol, illicit and
prescription drugs, and nicotine.
They are considered by many to be
the nation’s leading health problem.
• In 2010, more than 465,000 
Veterans were diagnosed with a
substance use disorder. Of those,
28 percent also had posttraumatic
stress disorder.
• About 1 in 4 deployed personnel
have alcohol-related behavior
problems, such as binge drinking.
About 1 in 8 non-deployed 
personnel have such problems.
• Due in part to aggressive eﬀorts
by VA in the area of smoking 
cessation, fewer Veterans in the 
VA system are smoking today than a
decade ago. In 1999, the prevalence
of smoking among Veterans in VA
care was 33 percent, and in 2008, it
was just under 20 percent—about
the same as for U.S. adults in general.
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VA investigators are exploring
risk factors for suicide in
Veterans and helping to 
improve risk assessments. 
They are also working to 
develop effective interventions
and identify crucial time periods
at which to intervene. Two 
VA centers are dedicated to 
research in  this area: the 
Center of Excellence for Suicide 
Prevention in Canandaigua,
N.Y., and the Mental Illness 
Research Education and 
Clinical Center in Denver. 
In addition, VA is part of a 
consortium set up by the Army
to mesh military and civilian
efforts in this area.  
Suicide Prevention
Recent Advances 
Exercise reduces suicide risk — A study of Veterans showed that regular exercise
reduced the risk of suicide. The study, by VA researchers in Denver, Palo Alto, and
Philadelphia, also showed that exercise improved sleep patterns and reduced the
symptoms of depression.  (Suicide and Life-Threatening Behavior, June 2013)
Brain changes linked with suicidal behavior — Veterans with traumatic brain
injury (TBI) and suicidal behaviors have a larger thalamus, compared with Veter-
ans with TBI but no suicidal behaviors. Researchers from the George E. Whalen
VAMC (Utah) compared three groups of Veterans: 40 healthy, 19 with TBI and sui-
cidal behaviors, and 15 with TBI and no suicidal behaviors. Both lobes of the thal-
amus were larger in Veterans with TBI and suicidal behaviors, compared with
other Veterans in the study. The thalamus, which relays signals within the brain, is
important in regulating sleep and has also been implicated in depression. 
(Frontiers in Psychiatry, Aug. 12, 2013)
Warning signs of suicide — Veterans who commit suicide within a week of 
receiving health care often exhibit warning signs, says a study by the Canandaigua
(N.Y.) VAMC. At their ﬁnal health care visit, such Veterans are more than three
times as likely as other Veterans to have talked about committing suicide, or
mentioned they have thought about it. They also are more than twice as likely 
to have shown psychotic symptoms, such as disorganized thoughts, unfounded
fears, and hallucinations. Identifying these warning signs during a Veteran’s
health care visit may help to reduce the risk of suicide. (Psychiatry Research, 
December 2012) 
It’s about trust — VA researchers in Portland conducted follow-up interviews with
Veterans who had shown evidence of suicidal thinking during risk assessments.
They identiﬁed four key themes: the importance of the relationship between the
Veteran and the clinician doing the assessment; the value of empathy and 
genuineness on the part of the clinician; the need for clear, direct language; 
and the importance of providing full information about the assessment process. 
(Journal of General Internal Medicine, September 2013)
Suicide Prevention
Facts about 
Suicide Prevention
• More than 30,000 Americans die
each year from suicide; about 20
percent are Veterans. 
• Veteran-speciﬁc risks include
multiple deployments, exposure to
combat/death, lengthy deploy-
ment, deployment to hostile areas,
service-related injuries, and physi-
cal or sexual assault while serving.
• Evidence suggests that since
2006, younger Veterans (ages 18-
29) who use VA health care are less
likely to commit suicide, compared
with those who do not. 
• VA provides a suicide prevention
hotline, 1-800-273-TALK. This has
rescued more than 20,000 actively
suicidal Veterans.
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VA researchers are conducting
cutting-edge research aimed at
improving care for Veterans
with traumatic brain injury
(TBI). VA research in this area
focuses on gaining a better 
understanding of the brain
changes that occur in TBI, 
refining screening and 
diagnostic tools, developing
and evaluating treatments, and
identifying coping strategies
for Veterans and their families.
Traumatic Brain Injury
Recent Advances 
The risk of chronic traumatic encephalopathy after TBI — Chronic traumatic
encephalopathy is a degenerative brain disease that occurs after repetitive TBI.
Researchers from the Boston VA analyzed brain tissue from 85 people with histories
of repetitive mild TBI. They found evidence of chronic traumatic encephalopathy
in 68 of them. Of those studied, 64 were athletes and 21 were Veterans, although
86 percent of the Veterans also were athletes.  (Brain, January 2013)
Molecules may be useful for prevention, treatment — Two proteins may 
help treat or prevent traumatic brain injury, according to research from the 
San Francisco VA. One study compared TBI eﬀects in mice with and without the
gene for Hsp70. This protein is one of a family of proteins that helps to protect
cells from stress. Mice that produced Hsp70 had smaller brain lesions, less bleeding
in the brain, and fewer TBI symptoms. Another study found that a molecule
called LM11A-31 protects TBI-damaged nerve cells and reverses impairments in
spatial memory. Both molecules may develop into treatments for TBI-related 
injuries and symptoms.  (Neurobiology of Disease, October 2013; Stem Cells, 
November, 2013)
Stroke risk increases in brain-injury patients — A study at the Ann Arbor VA
found a slightly increased risk for stroke in TBI patients. This study included data
on everyone who visited a California emergency department or was hospitalized
in California for TBI or non-TBI trauma from 2005 to 2009. This totaled more than
1 million people. Of these, 37 percent had TBI. People with TBI were slightly
younger, more likely to be male, and had more severe injuries. Over about 28
months, 1.1 percent of the TBI group had a stroke, compared with 0.9 percent of
the non-TBI group.  Because TBI can cause bleeding in the brain, it may increase
the risk for stroke. Or there may be other factors involved. This large study 
suggests that TBI patients and their clinicians need to be aware of the risk. 
(Neurology, July 2, 2013)
Traumatic Brain Injury
Facts about 
Traumatic Brain Injury
• Most TBI injuries are considered
mild, but even these cases can 
involve serious long-term eﬀects
on areas such as thinking ability,
memory, mood, and focus. 
Symptoms may also include
headaches, vision, and hearing
problems.
• TBIs can occur from direct contact
to the head, or when the brain is
shaken within the skull, such as
from a blast or whiplash during a
car accident.
• A recent survey of OEF/OIF
troops found that 11 percent of
women and 20 percent of men
screened positive for deployment-
related TBI.
• Treatment typically includes a
mix of cognitive, physical, speech,
and occupational therapy, along
with medication to control speciﬁc
symptoms, such as headaches or
anxiety. 
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VA researchers are designing
new assistive devices for 
the visually impaired and 
improving existing ones. They
are also exploring the use of
GPS and other technologies—
such as infrared signals or
computer vision—to aid indoor
and outdoor navigation for
blinded Veterans. Other areas
of investigation include the 
development of an artificial
retina to restore vision, and the
design and evaluation of new
tests and therapy techniques 
to address vision problems 
associated with traumatic
brain injury and posttraumatic
stress disorder.
Vision Loss
Recent Advances 
Vision problems under-diagnosed in Veterans with TBI — An ongoing study
is ﬁnding a high rate of vision problems in Veterans with traumatic brain injury
(TBI). Researchers from the Palo Alto VA are collecting data through 2015 on Vet-
erans with any form of TBI. A preliminary study on 50 Veterans with blast-related
TBI found that more than 65 percent had vision problems, and 77 percent re-
ported sensitivity to light. Other diﬃculties included problems with eye move-
ment, blurred vision, and problems focusing.  (Optometry and Vision Science,
February 2013)
Artiﬁcial retina could restore sight — A group at the Pittsburgh VA and
Carnegie Mellon University is developing a prosthetic retina. The work involves a
plastic ﬁlm the width of an eyelash, which is inserted behind the retina. From the
ﬁlm, ﬂexible electrodes send signals to retinal nerves. The signals are generated
by a microchip attached to the eye. Input comes from special eyeglasses. The
camera-like device is being tested in clinical studies. The work builds on 
VA-funded research from the Boston Retinal Implant Project.  (Carnegie Mellon
news release, June 8, 2012)
Telemedicine for high blood pressure also saves vision — The Durham 
VA-based Hypertension Intervention Nurse Telemedicine Study looked at the eﬀects
of telephone-based medication management and behavioral management on
high blood pressure in people with diabetes. A follow-up analysis found that 
patients whose blood pressure improved due to the intervention also had about
half the risk of worsening diabetic retinopathy, compared with those receiving
usual care. Diabetic retinopathy damages the retina and eventually can lead to
blindness.  (JAMA Ophthalmology, July 2013)
Detecting the progression of eye disease — A research group at the Iowa City
VA has found new medical applications for a decades-old statistical method used
in quality control to detect small changes that require corrective action. The
method is known as CUSUM (cumulative sum control chart). In a study involving
53 healthy patients and 103 patients with glaucoma, the researchers found
CUSUM charts to be an eﬀective aid in catching clinically signiﬁcant changes in
vision.  (Translational Vision Science and Technology, September 2013)
Vision Loss
Facts about Vision Loss
• About 160,000 Veterans in the
United States are legally blind, and
about 285,000 have glaucoma. 
• As many as 1.5 million Veterans
have vision problems that aﬀect
their daily activities. Many are
helped through VA’s network of
Low Vision Rehabilitation programs. 
• Vision loss will become more
common as more Korean- and 
Vietnam-era Veterans incur vision
loss due to age-related diseases. 
• Among the newest war Veterans,
many who have suﬀered brain 
injuries from blasts also experience
symptoms such as blurred vision,
double vision, sensitivity to light,
and diﬃculty reading. 
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Women are the fastest-growing
group of Veterans. In the past
25 years, the percentage of 
Veterans who are women has
more than doubled, to about 
10 percent. In response, VA has
focused additional attention 
on the unique or special health
needs of this population. 
Research aims to improve 
primary and reproductive
health care for women, and 
to help address the needs of
special populations, such as
aging female Veterans and those
with mental health conditions.
Many diseases common among
women—such as cancer,
osteoporosis, arthritis, and 
depression—are the focus of
biomedical studies and clinical
trials at numerous VA sites. 
Women’s Health
Recent Advances 
Heart-disease risk factors common — Women Veterans ages 35 to 64 are likely
to have at least one modiﬁable risk factor for heart disease, says a study from the
VA medical center in Bedford, Mass. Researchers used data on nearly 256,000 
female Veterans. Among the youngest age group (35 to 44), 14 percent had high
blood pressure, and a similar percentage had high cholesterol. Four percent had
diabetes, and 14 percent were obese. Risk factors increased with age. Heart 
disease is the leading cause of death in U.S. women.  (Journal of General Internal
Medicine, July 2013)
1 in 8 female Veterans has PTSD — Among a nationwide representative sample
of 3,611 female Veterans, 13 percent screened positive for posttraumatic stress
disorder. About 43 percent of the women in the study used VA health care. 
Although overall fewer than half the women used mental health services, those
receiving care through VA were nearly three times more likely to do so. The 
authors note that non-VA health care providers are less likely to be aware of
women’s Veteran status or their risk for PTSD.  (Journal of General Internal Medicine,
July 2013)
New biomarker for hip fracture risk — A VA team in Minneapolis identiﬁed a
blood protein that may predict hip fracture risk in older women. Researchers
studied 1,470 older women: 300 with hip fractures and 1,170 without. All had
been examined in the recent past, and blood samples were taken at that time.
The blood was checked for levels of cystatin C and creatinine. Both proteins are
used as markers of kidney function: higher levels mean worsening kidney function.
This study found that higher cystatin C levels were also associated with an increased
risk of hip fracture. Women with the highest levels were nearly twice as likely to
have broken a hip, compared with those who had the lowest levels. Creatinine
levels were not linked with hip fracture risk. The cystatin C relationship with hip
fracture was independent of all other known risk factors, including bone mineral
density. (Journal of Bone Mineral Research, June 2013)
Women’s Health
Facts about 
Women’s Health
• About half of female Veterans 
are married, and about half of
those who are married are in 
dual-military marriages. About 
11 percent of female Veterans 
are single mothers. 
• Among female Veterans seen 
in VA, about 1 in 5 reports having
experienced military sexual trauma.
• Among women treated by VA 
in 2009 and 2010, the top three 
diagnoses were PTSD, high blood
pressure, and depression.
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